HEADER ANTIVIRAL PROTEIN 16-MAY-22 7ZVK TITLE CRYSTAL STRUCTURE OF HUMAN STING IN COMPLEX WITH 3',3'-C-(2'F,2'DAMP- TITLE 2 IMP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING, LOC340061, HCG_1782396; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS STING, ANTIVIRAL, ACTIVATOR, ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.KLIMA,M.SMOLA,E.BOURA REVDAT 1 29-NOV-23 7ZVK 0 JRNL AUTH M.KLIMA,M.SMOLA,E.BOURA JRNL TITL CRYSTAL STRUCTURE OF HUMAN STING IN COMPLEX WITH JRNL TITL 2 3',3'-C-(2'F,2'DAMP-IMP) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 9289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 465 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.9300 - 4.0800 1.00 3020 159 0.2053 0.2666 REMARK 3 2 4.0800 - 3.2400 1.00 2915 154 0.2487 0.2771 REMARK 3 3 3.2400 - 2.8300 1.00 2900 152 0.2896 0.3250 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.412 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.784 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2895 REMARK 3 ANGLE : 0.487 3942 REMARK 3 CHIRALITY : 0.037 435 REMARK 3 PLANARITY : 0.004 502 REMARK 3 DIHEDRAL : 12.294 1087 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZVK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292123061. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS XDSAPP 2.0 REMARK 200 DATA SCALING SOFTWARE : XDS XDSAPP 2.0 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9289 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.830 REMARK 200 RESOLUTION RANGE LOW (A) : 45.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 8.200 REMARK 200 R MERGE (I) : 0.20010 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.50 REMARK 200 R MERGE FOR SHELL (I) : 1.73900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 4KSY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LITHIUM ACETATE, 20% (W/V) PEG REMARK 280 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y,Z REMARK 290 7555 -Y+1/2,X,Z+3/4 REMARK 290 8555 Y,-X+1/2,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 72.62800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 72.62800 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.02300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 72.62800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 9.01150 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 72.62800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.03450 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 72.62800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 72.62800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 18.02300 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 72.62800 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 27.03450 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 72.62800 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 9.01150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 140 REMARK 465 PRO A 141 REMARK 465 ALA A 142 REMARK 465 GLU A 143 REMARK 465 ILE A 144 REMARK 465 SER A 145 REMARK 465 ALA A 146 REMARK 465 VAL A 147 REMARK 465 CYS A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 GLY A 151 REMARK 465 ASN A 152 REMARK 465 PHE A 153 REMARK 465 TYR A 186 REMARK 465 ASN A 187 REMARK 465 ASN A 188 REMARK 465 LEU A 189 REMARK 465 LEU A 190 REMARK 465 ARG A 191 REMARK 465 GLY A 192 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 SER A 321 REMARK 465 SER A 322 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 ALA B 140 REMARK 465 PRO B 141 REMARK 465 ALA B 142 REMARK 465 GLU B 143 REMARK 465 ILE B 144 REMARK 465 SER B 145 REMARK 465 ALA B 146 REMARK 465 VAL B 147 REMARK 465 CYS B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 GLY B 151 REMARK 465 ASN B 152 REMARK 465 ASN B 187 REMARK 465 ASN B 188 REMARK 465 LEU B 189 REMARK 465 LEU B 190 REMARK 465 ARG B 191 REMARK 465 GLY B 192 REMARK 465 ALA B 193 REMARK 465 PRO B 317 REMARK 465 ALA B 318 REMARK 465 ASP B 319 REMARK 465 ASP B 320 REMARK 465 SER B 321 REMARK 465 SER B 322 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 GLU B 339 REMARK 465 GLU B 340 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 337 CG CD OE1 OE2 REMARK 470 TYR B 186 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 281 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 282 CG CD OE1 OE2 REMARK 470 ARG B 293 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 306 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -56.52 -121.42 REMARK 500 SER A 305 52.21 -90.13 REMARK 500 TYR B 167 -56.81 -120.66 REMARK 500 REMARK 500 REMARK: NULL DBREF1 7ZVK A 140 343 UNP A0A2R3XZB7_HUMAN DBREF2 7ZVK A A0A2R3XZB7 140 343 DBREF1 7ZVK B 140 343 UNP A0A2R3XZB7_HUMAN DBREF2 7ZVK B A0A2R3XZB7 140 343 SEQRES 1 A 204 ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY ASN SEQRES 2 A 204 PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE SEQRES 3 A 204 GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG SEQRES 4 A 204 ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG SEQRES 5 A 204 GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU SEQRES 6 A 204 ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO SEQRES 7 A 204 ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY SEQRES 8 A 204 ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER SEQRES 9 A 204 ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR SEQRES 10 A 204 CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE SEQRES 11 A 204 ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU SEQRES 12 A 204 ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU SEQRES 13 A 204 GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN SEQRES 14 A 204 CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SEQRES 15 A 204 SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG SEQRES 16 A 204 GLN GLU GLU LYS GLU GLU VAL THR VAL SEQRES 1 B 204 ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY ASN SEQRES 2 B 204 PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR ILE SEQRES 3 B 204 GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA ARG SEQRES 4 B 204 ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU ARG SEQRES 5 B 204 GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO LEU SEQRES 6 B 204 ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP PRO SEQRES 7 B 204 ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR GLY SEQRES 8 B 204 ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SER SEQRES 9 B 204 ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY THR SEQRES 10 B 204 CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU PHE SEQRES 11 B 204 ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG GLU SEQRES 12 B 204 ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR LEU SEQRES 13 B 204 GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN ASN SEQRES 14 B 204 CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SER SEQRES 15 B 204 SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU ARG SEQRES 16 B 204 GLN GLU GLU LYS GLU GLU VAL THR VAL HET K1L B 401 88 HETNAM K1L 9-[(1~{R},6~{R},8~{R},9~{R},10~{R},15~{R},17~{R}, HETNAM 2 K1L 18~{S})-8-(6-AMINOPURIN-9-YL)-9-FLUORANYL-3,12,18- HETNAM 3 K1L TRIS(OXIDANYL)-3,12-BIS(OXIDANYLIDENE)-2,4,7,11,13- HETNAM 4 K1L PENTAOXA-3$L^{5},12$L^{5}- HETNAM 5 K1L DIPHOSPHATRICYCLO[13.3.0.0^{6,10}]OCTADECAN-17-YL]- HETNAM 6 K1L 3~{H}-PURIN-6-ONE FORMUL 3 K1L C21 H24 F N9 O11 P2 HELIX 1 AA1 VAL A 155 TYR A 167 1 13 HELIX 2 AA2 TYR A 167 LEU A 172 1 6 HELIX 3 AA3 GLU A 174 HIS A 185 1 12 HELIX 4 AA4 ASN A 211 ASP A 216 1 6 HELIX 5 AA5 ALA A 262 TYR A 274 1 13 HELIX 6 AA6 SER A 280 GLU A 282 5 3 HELIX 7 AA7 ASP A 283 ALA A 302 1 20 HELIX 8 AA8 SER A 324 GLU A 336 1 13 HELIX 9 AA9 ASN B 154 TYR B 167 1 14 HELIX 10 AB1 TYR B 167 HIS B 185 1 19 HELIX 11 AB2 ASN B 211 ASP B 216 1 6 HELIX 12 AB3 ALA B 262 TYR B 274 1 13 HELIX 13 AB4 SER B 275 GLY B 278 5 4 HELIX 14 AB5 ARG B 281 ALA B 302 1 22 HELIX 15 AB6 SER B 324 GLU B 336 1 13 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O GLU A 246 N ARG A 220 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O GLN A 252 N GLU A 249 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N LEU A 201 O GLU A 260 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ILE A 312 N LEU A 202 SHEET 1 AA2 2 GLN A 228 ARG A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O TYR A 240 N GLN A 228 SHEET 1 AA3 5 ILE B 219 LYS B 224 0 SHEET 2 AA3 5 SER B 243 GLU B 249 -1 O ILE B 244 N ASP B 223 SHEET 3 AA3 5 GLN B 252 TYR B 261 -1 O CYS B 257 N TYR B 245 SHEET 4 AA3 5 LEU B 198 PRO B 203 1 N LEU B 201 O GLU B 260 SHEET 5 AA3 5 CYS B 309 TYR B 314 1 O ILE B 312 N LEU B 202 SHEET 1 AA4 2 GLN B 228 ARG B 232 0 SHEET 2 AA4 2 ILE B 235 TYR B 240 -1 O TYR B 240 N GLN B 228 CRYST1 145.256 145.256 36.046 90.00 90.00 90.00 I 41 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006884 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006884 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027742 0.00000